Conjunctival Neoplasms

Tumors or cancer of the CONJUNCTIVA.

Also Known As:

Conjunctival Neoplasm; Neoplasm, Conjunctival; Neoplasms, Conjunctival

Networked: 9 relevant articles (0 outcomes, 1 trials/studies)

Disease Context: Research Results

Neoplasms: 1324753
- Neoplasms by Site: 4
  - Eye Neoplasms: 61
    - Conjunctival Neoplasms: 9
      - Lipoma of the Conjunctiva
Eye Diseases: 3522
- Conjunctival Diseases: 90
  - Conjunctival Neoplasms: 9
    - Lipoma of the Conjunctiva
- Eye Neoplasms: 61
  - Conjunctival Neoplasms: 9
    - Lipoma of the Conjunctiva

Related Diseases

1.	Central Serous Chorioretinopathy
2.	Choroidal Neovascularization
3.	Telangiectasis (Telangiectasia)
4.	Macular Edema
5.	von Hippel-Lindau Disease (von Hippel Lindau Disease)

Experts

1.	Abramson, David H: 1 article (03/2015)
2.	Barker, Christopher A: 1 article (03/2015)
3.	Cohen, Gil'ad N: 1 article (03/2015)
4.	Marr, Brian P: 1 article (03/2015)
5.	McCormick, Beryl: 1 article (03/2015)
6.	Williamson, Matthew J: 1 article (03/2015)
7.	Esen, Ebru: 1 article (11/2014)
8.	Çiloğlu, Emine: 1 article (11/2014)
9.	Özcan, Altan A: 1 article (11/2014)
10.	Şimdivar, Göksu H: 1 article (11/2014)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Conjunctival Neoplasms:

1.	Retinaldehyde (Retinal)IBA 12/01/2007 - "Phase I to III clinical trials to confirm the role of ranibizumab in the treatment of choroidal neovascularization (phase II and III), diabetic macular edema (phase II and III), retinal venous occlusion (phase II and III), telangiectasia (phase I and II), central serous chorioretinopathy (phase I), polypoidal choroidal vasculopathy (phase I/II), conjunctival neoplasms (phase I) and von Hippel-Lindau syndrome (phase I) are ongoing."
2.	Ranibizumab (Lucentis)FDA Link 12/01/2007 - "Phase I to III clinical trials to confirm the role of ranibizumab in the treatment of choroidal neovascularization (phase II and III), diabetic macular edema (phase II and III), retinal venous occlusion (phase II and III), telangiectasia (phase I and II), central serous chorioretinopathy (phase I), polypoidal choroidal vasculopathy (phase I/II), conjunctival neoplasms (phase I) and von Hippel-Lindau syndrome (phase I) are ongoing."
3.	Mitomycin (Mitomycin-C)FDA LinkGeneric 06/01/2005 - "Mitomycin C (MMC) is a cytostatic agent topically used in conjunctival neoplasms, secondary to glaucoma filtering, pterygium, and strabismus surgery to increase the success rate. " 03/01/2005 - "Information reported on this topic in the Medline database (1966-2004) was searched using corneo-conjunctival neoplasm, 5-fluorouracil, mitomycin C, and interferon ca2b as key words. "
4.	Cytostatic AgentsIBA 06/01/2005 - "Mitomycin C (MMC) is a cytostatic agent topically used in conjunctival neoplasms, secondary to glaucoma filtering, pterygium, and strabismus surgery to increase the success rate. "
5.	Phosphorus (Red Phosphorus)IBA 03/01/2015 - "To describe the results of patients with diffuse conjunctival neoplasms treated with radioactive phosphorus 32 (32P)-impregnated flexible film. " 03/01/2015 - "Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity."
6.	MucinsIBA 01/01/2014 - "Due to its rare incidence, difficult clinical diagnosis, and accompanying poor prognosis, conjunctival mucoepidermoid carcinoma should always be considered in the differential diagnosis of conjunctival neoplasms, and full histopathologic examination, including mucin-staining techniques, of all suspicious conjunctival biopsies should occur. "
7.	InterferonsIBA 03/01/2005 - "Information reported on this topic in the Medline database (1966-2004) was searched using corneo-conjunctival neoplasm, 5-fluorouracil, mitomycin C, and interferon ca2b as key words. "
8.	Fluorouracil (Carac)FDA LinkGeneric 03/01/2005 - "Information reported on this topic in the Medline database (1966-2004) was searched using corneo-conjunctival neoplasm, 5-fluorouracil, mitomycin C, and interferon ca2b as key words. "
9.	Bevacizumab (Avastin)FDA Link 11/01/2014 - "Topical bevacizumab is an effective treatment to reduce the tumor size before surgery and may be a good alternative for adjuvant therapy of conjunctival neoplasms."

Therapies and Procedures

1.	Cryotherapy (Therapy, Cold) 07/01/1987 - "[Cryotherapy of conjunctival neoplasms]." 01/01/1977 - "[Results of a 4-and-1/2 year experience with cryotherapy for eyelid and conjunctival neoplasms]." 01/01/2013 - "Surgical treatment for conjunctival neoplasms, with wide local excision, with or without supplemental cryotherapy to the surgical margins represents the treatment of choice for this pathology. "
2.	Therapeutics 03/01/2005 - "The goal of therapy for corneo-conjunctival neoplasm is lesion removal, with the most widespread procedure being complete tumor resection with or without associated chemotherapy lines. " 11/01/2014 - "Topical bevacizumab is an effective treatment to reduce the tumor size before surgery and may be a good alternative for adjuvant therapy of conjunctival neoplasms."
3.	Drug Therapy (Chemotherapy) 03/01/2005 - "To determine the clinical experience published regarding the effectiveness of the various drug therapies for cor-neo-conjunctival neoplasm. " 03/01/2005 - "[Drug therapy for corneo-conjunctival neoplasm]." 03/01/2005 - "The goal of therapy for corneo-conjunctival neoplasm is lesion removal, with the most widespread procedure being complete tumor resection with or without associated chemotherapy lines. "
4.	Brachytherapy 03/01/2015 - "Our results show the use of an intraoperative high-dose rate of 32P brachytherapy in selected cases of recalcitrant diffuse conjunctival neoplasms. " 03/01/2015 - "Intraoperative high-dose rate of radioactive phosphorus 32 brachytherapy for diffuse recalcitrant conjunctival neoplasms: a retrospective case series and report of toxicity."